Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
51.96(c) 51.62(c) 51.1(c) 51.71(c) 51.18(c) Last
7 454 062 6 014 078 5 708 805 6 322 404 5 937 007 Volume
+1.31% -0.65% -1.01% +1.19% -1.02% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/01Ex-dividend day
Surperformance© rating of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More about the company
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 742 M
EBIT 2014 3 295 M
Net income 2014 2 771 M
Finance 2014 228 M
Yield 2014 2,78%
Sales 2015 15 602 M
EBIT 2015 3 023 M
Net income 2015 2 609 M
Finance 2015 876 M
Yield 2015 2,85%
PER 2014 31,35
PER 2015 30,48
EV / Sales 2014 5,43x
EV / Sales 2015 5,44x
Capitalization 85 730 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
6h ago BRISTOL MYERS SQUIBB : to Transfer $1.4 Billion in U.S. Pension Obligations to P..
1d ago BRISTOL MYERS SQUIBB : European Medicines Agency Validates the Marketing Authori..
1d ago BRISTOL MYERS SQUIBB : Assigned Patent
1d ago BRISTOL MYERS SQUIBB : Positive Phase 3 Data for Opdivo (nivolumab) in Advanced ..
1d ago BRISTOL MYERS SQUIBB : World Heart Federation Receives Donation from Bristol-Mye..
4d ago BRISTOL MYERS SQUIBB : Announces Multiple Regulatory Milestones for Opdivo (nivo..
5d ago BRISTOL MYERS SQUIBB : World Heart Federation Announces a Donation from Bristol-..
5d ago BRISTOL MYERS SQUIBB : Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson..
6d ago BRISTOL MYERS SQUIBB : Trademark Application for "LAMNETIQ" Filed by Bristol-Mye..
6d ago BRISTOL MYERS SQUIBB : Trademark Application for "LAMNETIK" Filed
6d ago BRISTOL MYERS SQUIBB : An Application for the Trademark "LAMNETIC" Has Been File..
6d ago BRISTOL MYERS SQUIBB : Researchers from Bristol-Myers Squibb Describe Findings i..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF